Symptom Clusters in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy: A Scoping Review

Dan Liu, Liyan Zhang, Chengcheng Zhang, Yixuan Wang, Zhenzhen Su

Open source

DOI
10.17605/osf.io/nxr53
Published
2026
Container
Not recorded
Publisher
OSF Registries
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17605/osf.io/nxr53,
  title = {Symptom Clusters in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy: A Scoping Review},
  author = {Dan Liu and Liyan Zhang and Chengcheng Zhang and Yixuan Wang and Zhenzhen Su},
  year = {2026},
  doi = {10.17605/osf.io/nxr53},
  url = {https://doi.org/10.17605/osf.io/nxr53}
}

RIS

TY  - JOUR
TI  - Symptom Clusters in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy: A Scoping Review
AU  - Dan Liu
AU  - Liyan Zhang
AU  - Chengcheng Zhang
AU  - Yixuan Wang
AU  - Zhenzhen Su
PY  - 2026
DO  - 10.17605/osf.io/nxr53
UR  - https://doi.org/10.17605/osf.io/nxr53
ER  - 

APA

Liu, D., Zhang, L., Zhang, C., Wang, Y., & Su, Z. (2026). Symptom Clusters in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy: A Scoping Review. https://doi.org/10.17605/osf.io/nxr53

Source records